Prognostic Factors Associated With a Stable MR4.5 Achievement in Chronic Myeloid Leukemia Patients Treated With Imatinib
Oncotarget - United States
doi 10.18632/oncotarget.23691
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 26, 2017
Authors
Publisher
Impact Journals, LLC